Literature DB >> 21371167

An evaluation of intrathecal bupivacaine combined with intrathecal or intravenous clonidine in children undergoing orthopedic surgery: a randomized double-blinded study.

Jian-Ping Cao1, Xiao-Yong Miao, Jian Liu, Xue-Yin Shi.   

Abstract

BACKGROUND: Propofol is a popular agent for providing intraoperative sedation in pediatric population during lumbar puncture and spinal anesthesia. Adjuvant-like clonidine is used increasingly in pediatric anesthesia to provide postoperative analgesia with a local anesthetic agent. The aim of this study was to assess the effects of intrathecal and intravenous clonidine on postoperative analgesia/sedation and intraoperative requirements of propofol after intrathecal bupivacaine for orthopedic surgery in children.
METHODS: Fifty-nine ASA I and II children aged 6-8 year undergoing orthopedic surgery were randomized to receive intrathecal 0.5% bupivacaine 0.2-0.4 mg·kg(-1) and intravenous 2 ml saline (Group B), intrathecal 0.5% bupivacaine 0.2-0.4 mg·kg(-1) plus 1 μg·kg(-1) clonidine and intravenous 2 ml saline (Group BCit), and 0.5% bupivacaine 0.2-0.4 mg·kg(-1) and intravenous 1 μg·kg(-1) clonidine in 2 ml of saline (Group BCiv). Intraoperative sedation was maintained with 20-50 μg·kg(-1)·min(-1) of propofol infusion. The requirements of propofol, time to first rescue analgesia, and postoperative pain or sedation scores were assessed. The duration of motor and sensory blocks and perioperative adverse events were determined.
RESULTS: Clonidine significantly prolonged the time to first rescue analgesia and reduced the requirements of propofol sedation whether administered intravenously or intrathecally. The mean Children and Infants Postoperative Pain Scale scores of children were significantly lower in groups BCit and BCiv than in group B. Postoperative sedation scores were higher in groups BCit and BCiv than in group B. Intrathecal clonidine significantly prolonged the time to regression of the sensory block and recovery of motor block. There were no significant differences among the three groups regarding the incidence of perioperative adverse events.
CONCLUSION: Intrathecal or intravenous clonidine similarly provided better postoperative analgesia and sedation and reduced the requirements of propofol. Only intrathecal clonidine prolonged the duration of sensory and motor blocks.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371167     DOI: 10.1111/j.1460-9592.2011.03543.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  6 in total

1.  Intrathecal clonidine in the neonatal rat: dose-dependent analgesia and evaluation of spinal apoptosis and toxicity.

Authors:  Suellen M Walker; Marjorie Grafe; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-03-30       Impact factor: 5.108

Review 2.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

3.  The effect of pretreatment with clonidine on propofol consumption in opium abuser and non-abuser patients undergoing elective leg surgery.

Authors:  Morteza Jabbari Moghadam; Davood Ommi; Alireza Mirkheshti; Mehdi Shadnoush; Ali Dabbagh
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

4.  Clonidine: an old friend newly rediscovered.

Authors:  Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2011-07-01

5.  Intraoperative Comparison and Evaluation of Intrathecal Bupivacaine Combined with Clonidine versus Fentanyl in Children Undergoing Hernia Repair or Genital Surgery: A Prospective, Randomized Controlled Trial.

Authors:  Kumar Parag; Madhuri Sharma; Hariom Khandelwal; Nidhi Anand; Nishith Govil
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

Review 6.  Spinal anesthesia in children: A review.

Authors:  Anju Gupta; Usha Saha
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.